Nuwellis (NUWE) Competitors $4.89 -0.04 (-0.81%) Closing price 04:00 PM EasternExtended Trading$4.86 -0.03 (-0.72%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. NXGL, NVNO, FEMY, ALUR, NXL, IINN, BTCY, DHAI, INBS, and MHUAShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include NexGel (NXGL), enVVeno Medical (NVNO), Femasys (FEMY), Allurion Technologies (ALUR), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), Biotricity (BTCY), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors NexGel enVVeno Medical Femasys Allurion Technologies Nexalin Technology Inspira Technologies OXY B.H.N. Biotricity DIH Holding US Intelligent Bio Solutions Meihua International Medical Technologies NexGel (NASDAQ:NXGL) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends. Which has more volatility & risk, NXGL or NUWE? NexGel has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500. Do insiders & institutionals hold more shares of NXGL or NUWE? 2.2% of NexGel shares are owned by institutional investors. Comparatively, 3.1% of Nuwellis shares are owned by institutional investors. 20.6% of NexGel shares are owned by company insiders. Comparatively, 20.1% of Nuwellis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is NXGL or NUWE more profitable? NexGel has a net margin of -25.02% compared to Nuwellis' net margin of -176.45%. NexGel's return on equity of -49.37% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets NexGel-25.02% -49.37% -25.68% Nuwellis -176.45%-1,424.01%-187.69% Which has stronger valuation & earnings, NXGL or NUWE? NexGel has higher earnings, but lower revenue than Nuwellis. NexGel is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexGel$8.69M2.07-$3.28M-$0.40-5.58Nuwellis$8.74M0.50-$11.16M-$35.36-0.14 Does the media prefer NXGL or NUWE? In the previous week, Nuwellis had 2 more articles in the media than NexGel. MarketBeat recorded 3 mentions for Nuwellis and 1 mentions for NexGel. Nuwellis' average media sentiment score of 1.00 beat NexGel's score of -1.00 indicating that Nuwellis is being referred to more favorably in the news media. Company Overall Sentiment NexGel Negative Nuwellis Positive Do analysts rate NXGL or NUWE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNexGel beats Nuwellis on 8 of the 15 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.45M$6.90B$5.75B$9.85BDividend YieldN/A1.22%6.67%4.51%P/E Ratio-0.1426.0678.4326.42Price / Sales0.5070.07546.94119.09Price / CashN/A21.6037.0558.92Price / Book0.084.9010.916.06Net Income-$11.16M$178.27M$3.29B$266.28M7 Day Performance-5.60%-0.61%0.01%-0.76%1 Month Performance-26.02%1.88%7.06%3.83%1 Year Performance-88.91%9.93%50.09%24.39% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis2.2803 of 5 stars$4.89-0.8%N/A-91.0%$4.45M$8.74M-0.1470Short Interest ↓NXGLNexGel0.4524 of 5 stars$2.35-0.4%N/A-18.1%$19.04M$8.69M0.0010Positive NewsNVNOenVVeno Medical1.8177 of 5 stars$0.89-7.9%N/A-85.3%$18.67MN/A-0.7430FEMYFemasys3.4326 of 5 stars$0.38-27.0%$7.33+1,850.4%-66.1%$16.78M$1.63M0.0030Short Interest ↓High Trading VolumeALURAllurion Technologies3.3321 of 5 stars$2.18-2.7%$22.83+947.4%-87.5%$16.70M$32.11M0.00501Positive NewsShort Interest ↓NXLNexalin Technology2.0507 of 5 stars$0.85+1.5%$5.00+490.5%-6.7%$14.53M$170K0.003Short Interest ↑Gap DownIINNInspira Technologies OXY B.H.N.3.3713 of 5 stars$1.18+3.5%$2.00+69.5%+4.5%$14.39MN/A0.0020Positive NewsShort Interest ↓Analyst RevisionBTCYBiotricityN/A$0.57-12.9%N/A+63.3%$14.18M$12.06M-0.5340News CoverageHigh Trading VolumeDHAIDIH Holding US1.2308 of 5 stars$0.27-4.0%N/A-88.2%$13.25M$64.47M0.00N/AShort Interest ↓Gap DownINBSIntelligent Bio Solutions0.1051 of 5 stars$1.46-0.5%N/A+18.8%$13.20M$3.05M-0.7110MHUAMeihua International Medical Technologies1.7375 of 5 stars$0.43+4.9%N/A-59.9%$13.08M$96.90M0.00620Short Interest ↓ Related Companies and Tools Related Companies NXGL Alternatives NVNO Alternatives FEMY Alternatives ALUR Alternatives NXL Alternatives IINN Alternatives BTCY Alternatives DHAI Alternatives INBS Alternatives MHUA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.